Other studies have also identified Cst upregulation in the APP/PS1 mice cortex of at 23–24 months old [90], in the PFC of AD patients [91], and in disease-associated microglia (DAM), where the upregulation also observed was found to be Trem2-dependent [92]. This evidence concerns the gene PSEN1 and Alzheimer disease.